The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial

Journal of Urology

Volumn 145, Issue 3, 1991, Pages 459-464

  Skinner, D G ^a   Daniels, J R ^a   Russell, C A ^a   Lieskovsky, G ^a   Boyd, S D ^a   Nichols, P ^a   Kern, W ^a   Sakamoto, J ^a   Krailo, M ^a   Groshen, S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bladder; Carcinoma, transitional cell; Drug therapy, combination

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TRANSITIONAL CELL CARCINOMA;

EID: 0025822201     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(17)38368-4     Document Type: Article

References (23)

1. D.G. Skinner G. Lieskovsky Management of invasive and high-grade bladder cancer Diagnosis and Management of Genitourinary Cancer 1988 W. B. Saunders Co. Philadelphia 295 chapt. 16
2. D.G. Skinner G. Lieskovsky Technique of radical cystectomy Diagnosis and Management of Genitourinary Cancer 1988 W. B. Saunders Co. Philadelphia 607 chapt. 42
3. C.J. Logothetis D.E. Johnson C. Chong F.H. Dexeus A. Sella S. Ogden T. Smith D.A. Swanson R.J. Babaian K.I. Wishnow A. von Eschenbach Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update J. Clin. Oncol. 6 1988 1590
4. C.N. Sternberg A. Yagoda H.I. Scher R.C. Watson T. Ahmed L.R. Weiselberg N. Geller P.S. Hollander H.W. Herr P.C. Sogani M.J. Morse W.F. Whitmore Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium J. Urol. 133 1985 403
5. C.N. Sternberg A. Yagoda H.I. Scher R.C. Watson H.W. Herr M.J. Morse P.C. Sogani E.D. Vaughan Jr. N. Bander L.R. Weiselberg N. Geller P.S. Hollander R. Lipperman W.R. Fair W.F. Whitmore Jr. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium J. Urol. 139 1988 461
6. I.F. Tannock M. Gospodarowicz W.K. Evans Chemotherapy for metastatic transitional carcinoma of the urinary tract: a prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failure Cancer 51 1983 216
7. I. Tannock M. Gospodarowicz J. Connolly M. Jewett MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience J. Urol. 142 1989 289
8. D.G. Skinner Current state of classification and staging of bladder cancer Cancer Res. 37 1977 2838
9. rd ed. 1978 International Union Against Cancer Geneva
10. A. Bergkvist A. Ljungqvist G. Moberger Classification of bladder tumours based on the cellular pattern Acta Chir. Scand. 130 1965 371
11. D.R. Taves Minimization: a new method of assigning patients to treatment and control groups J. Clin. Pharm. Ther. 15 1974 443
12. J.R. Daniels A.M. Daniels E.E. Luck B. Whitman J.T. Casagrande D.G. Skinner Chemosensitivity of human neoplasms with in vitro clone formation. Experience at the University of Southern California—Los Angeles County Medical Center Cancer Chemother. Pharm. 6 1981 245
13. R. Peto M.C. Pike P. Armitage N.E. Breslow D.R. Cox S.V. Howard N. Mantel K. McPherson J. Petro P.G. Smith Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design Brit. J. Cancer 34 1976 585
14. E.L. Kaplan P. Meier Nonparametric estimation from incomplete observations J. Amer. Stat. Ass. 53 1958 457
15. R.E. Tarone J. Ware On distribution-free tests for equality of survival distributions Biometrika 64 1977 156
16. J.R. Daniels D.G. Skinner G. Lieskovsky Chemotherapy of carcinoma of bladder D.G. Skinner G. Lieskovsky Diagnosis and Management of Genitourinary Cancer 1988 W. B. Saunders Co. Philadelphia 313 chapt. 17
17. J. Sternberg R.B. Bracken P.B. Handel D.E. Johnson Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report J.A.M.A. 238 1977 2282
18. C.J. Logothetis F.H. Dexeus A. Sella R.J. Amato L.D. Finn A prospective randomized trial of CISCA vs M-VAC chemotherapy in advanced metastatic urothelial tumors J. Urol. 141 1989 216A abstract 187
19. B.L. Hillcoat D. Raghavan J. Matthews R. Kefford K. Yuen R. Woods I. Olver J. Bishop B. Pearson G. Coorey J. Levi R.L. Abbott R. Aroney P.G. Gill R. McLennan A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract J. Clin. Oncol. 7 1989 706
20. H.I. Scher Should single agents be standard therapy for urothelial tract tumors? J. Clin. Oncol. 7 1989 694
21. M.S. Soloway A. Einstein M.P. Corder W. Bonney G.R. Prout Jr. J. Coombs A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A study Cancer 52 1983 767
22. J.D. Khandekar P.V. Elson W.D. DeWys R.E. Slayton D.T. Harris Comparative activity and toxicity of cis-diaminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in dissemin.ated transitional cell carcinomas of the urinary tract J. Urol. Oncol. 3 1985 539
23. M. Troner R. Birch G.A. Omura S. Williams Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial J. Urol. 137 1987 660